NCT05325606

Brief Summary

Study the prevalence of strokes in the emergency department (ED) and their possible eligibility for thrombolysis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

March 14, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 13, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

February 28, 2024

Status Verified

November 1, 2023

Enrollment Period

4.5 years

First QC Date

March 14, 2022

Last Update Submit

February 27, 2024

Conditions

Keywords

strokethrombolysisTunisia

Outcome Measures

Primary Outcomes (2)

  • Stroke prevalence

    After entering the ED , the patient will have a radiological and biological screening to establish his right diagnostic and then we have stroke prevalence in the ED.

    1day

  • Modified Rankin Scale (MRS) score change

    After discharge from ED, patients were called back in order to know information about the quality of life and the search for persistent complications.

    After a month , six month , 1 year

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with stroke symptoms and accept to enroll the study .

You may qualify if:

  • All patients with stroke symptoms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nouira Semir

Monastir, 5060, Tunisia

RECRUITING

MeSH Terms

Conditions

Ischemic StrokeThrombotic StrokeStroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Nouira Semir, Professor

    University of Monastir

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nouira Semir, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, A head of Emmergency Departement in Monastir

Study Record Dates

First Submitted

March 14, 2022

First Posted

April 13, 2022

Study Start

June 1, 2020

Primary Completion

December 1, 2024

Study Completion

January 1, 2025

Last Updated

February 28, 2024

Record last verified: 2023-11

Locations